The efficacy of stenting in the iliofemoral vein of patients with venous obstruction and secondary lymphedema from malignancy
Journal of Vascular Surgery: Venous and Lymphatic Disorders · 2023
DOI: 10.1016/j.jvsv.2023.01.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Vascular Surgery: Venous and Lymphatic Disorders, 2023. Verfasst von Xiangtao Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Vascular Diseases, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
OBJECTIVE: To investigate the safety and effectiveness of venous stenting in patients with chronic iliofemoral venous obstruction and secondary lymphedema from malignancy. METHODS: From July 2012 to December 2020, patients with iliofemoral venous obstruction and secondary lymphedema who underwent venous stenting in our institution were reviewed retrospectively. Clinical characteristics, surgical complications, and symptom relief were assessed. Stent patency was evaluated with duplex ultrasound or computed tomographic venography. Twelve-month outcomes were reported. RESULTS: Fifty-three patients with concurrent secondary lymphedema who had stents placed for iliofemoral venous obstruction were included. There were 42 females, and the mean age was 56.9 years. Nonthrombotic iliac vein lesions were identified in 16 patients (30.1%). Immediate technical success was 100%, with an average of two stents implanted. The median Villalta score, and Chronic Venous Disease Quality of Life quality of life questionnaire scores decreased from 12 (IQR, 10-15) and 58 (IQR, 50-66) at baseline, respectively, to 5 (interquartile range [IQR], 4-6) and 28 (IQR, 22-45) at 12 months after the procedure (P < .05), showing significant improvement in the quality of life. At the end of a median follow-up of 12 months (range, 3-25 months), the cumulative primary, assisted primary, and secondary patency rates were 70.8%, 76.9%, and 90.1%, respectively. CONCLUSIONS: In patients with secondary lymphedema from malignancy, venous stent placement is safe and effective for iliofemoral venous obstruction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Vascular Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
- Department of Vascular Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China. Electronic address: vascularsjt@163.com.
Zitieren
APA
Li, X., Wang, Z., Jing, Z., Niu, L., Zhang, H., Feng, Y., Zhang, C., Zhang, F., & Luo, X. (2023). The efficacy of stenting in the iliofemoral vein of patients with venous obstruction and secondary lymphedema from malignancy. Journal of Vascular Surgery: Venous and Lymphatic Disorders. https://doi.org/10.1016/j.jvsv.2023.01.005
Vancouver
Li X, Wang Z, Jing Z, Niu L, Zhang H, Feng Y, et al. The efficacy of stenting in the iliofemoral vein of patients with venous obstruction and secondary lymphedema from malignancy. Journal of Vascular Surgery: Venous and Lymphatic Disorders. 2023. doi:10.1016/j.jvsv.2023.01.005
BibTeX
@article{Li2023,
author = {Li, Xiangtao and Wang, Zhenni and Jing, Zongxu and Niu, Luyuan and Zhang, Huan and Feng, Yaping and Zhang, Changming and Zhang, Fuxian and Luo, Xiaoyun},
title = {The efficacy of stenting in the iliofemoral vein of patients with venous obstruction and secondary lymphedema from malignancy},
journal = {Journal of Vascular Surgery: Venous and Lymphatic Disorders},
year = {2023},
doi = {10.1016/j.jvsv.2023.01.005}
}
EUVIMED